Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Fritsche

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Cancer Research|September 1, 1984
Pharmacokinetic study of partially pure gamma-interferon in cancer patientsJ U Gutterman, M G Rosenblum, A Rios, et al.
The International Journal of Biological Markers|October 9, 2007
Five-year stability study of free and total prostate-specific antigen concentrations in serum specimens collected and stored at -70 degrees C or lessD A Scaramuzzino, K Schulte, B N Mack, et al.
American Journal of Clinical Pathology|March 1, 1980
Carcinoembryonic antigen levels in malignant pleural fluids obtained from patients with mammary cancerA DiStefano, C K Tashima, H A Fritsche, et al.
Annals of Clinical and Laboratory Science|March 1, 1997
Underestimation of monoclonal proteins by agarose serum protein electrophoresisC Y Chang, H A Fritsche, A B Glassman, et al.
Cancer Detection and Prevention|February 18, 1998
The effect of 13-cis-retinoic acid chemoprevention on human serum retinol levelsS M Lippman, S E Benner, H A Fritsche, et al.
Cancer|March 1, 1989
The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapyR L Theriault, G N Hortobagyi, H A Fritsche, et al.
The Journal of Urology|May 24, 2001
Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./mlK Okihara, H A Fritsche, A Ayala, et al.
Urology|February 11, 1998
Evaluation of prostAsure index in the detection of prostate cancer: a preliminary reportR J Babaian, H A Fritsche, Z Zhang, et al.
The Journal of Urology|February 15, 2001
The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategyR J Babaian, D A Johnston, W Naccarato, et al.
Journal of Clinical Pharmacology|August 1, 1988
The correlation of vinblastine pharmacokinetics to toxicity in testicular cancer patientsC D Chong, C J Logothetis, N Savaraj, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Cancer Research|September 1, 1984
Pharmacokinetic study of partially pure gamma-interferon in cancer patientsJ U Gutterman, M G Rosenblum, A Rios, et al.
The International Journal of Biological Markers|October 9, 2007
Five-year stability study of free and total prostate-specific antigen concentrations in serum specimens collected and stored at -70 degrees C or lessD A Scaramuzzino, K Schulte, B N Mack, et al.
American Journal of Clinical Pathology|March 1, 1980
Carcinoembryonic antigen levels in malignant pleural fluids obtained from patients with mammary cancerA DiStefano, C K Tashima, H A Fritsche, et al.
Annals of Clinical and Laboratory Science|March 1, 1997
Underestimation of monoclonal proteins by agarose serum protein electrophoresisC Y Chang, H A Fritsche, A B Glassman, et al.
Cancer Detection and Prevention|February 18, 1998
The effect of 13-cis-retinoic acid chemoprevention on human serum retinol levelsS M Lippman, S E Benner, H A Fritsche, et al.
Cancer|March 1, 1989
The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapyR L Theriault, G N Hortobagyi, H A Fritsche, et al.
The Journal of Urology|May 24, 2001
Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./mlK Okihara, H A Fritsche, A Ayala, et al.
Urology|February 11, 1998
Evaluation of prostAsure index in the detection of prostate cancer: a preliminary reportR J Babaian, H A Fritsche, Z Zhang, et al.
The Journal of Urology|February 15, 2001
The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategyR J Babaian, D A Johnston, W Naccarato, et al.
Journal of Clinical Pharmacology|August 1, 1988
The correlation of vinblastine pharmacokinetics to toxicity in testicular cancer patientsC D Chong, C J Logothetis, N Savaraj, et al.
Pageof 8